Abstract
Pharmacovigilance is the need of hour for use of topical steroids because the irrational use of topical steroids may harm the patients in long and short term; the outcome of such treatments can be assessed by using pharmacovigilance as a scientific tool to assess safety of medicine. Pharmacovigilance system of some developed countries is very strong, while in developing and poor countries, it is still in infancy state. The role of international bodies like ICH, CIOMS, WHO-UMC is very significant for harmonising the process of pharmacovigilance across the world. In this chapter, authors tries to establish the need of pharmacovigilance to ascertain frequency of rarely reported cases due to steroids and other drugs; an analysis of International ADR database is presented to show the culture of reporting across the world.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kumar R, Kumar P, Kaur I, Kalaiselvan V, Singh GN. Best practices for improving quality of individual case safety reports in pharmacovigilance. Ther Innov Regul Sci. 2016;50(4):464–71.
Vivekanandan K, Arunabh T, Kumar R, Prasad T, Singh GN. Quantitative methods for identification of signals. Ther Innov Regul Sci. 2015;49(6):898–902.
Vivekanandan K, Kumar R, Prasad T, Arunabh T, Singh GN. Status of documentation grading and completeness score for Indian individual case safety reports. Indian J Pharmacol. 2015;47:325–7.
Coondoo A, Phiske M, Verma S, Lahiri K. Side effects of topical steroids: a long overdue revisit. Indian Dermatol Online J. 2014;5(4):416–25.
WHO, 1972. http://apps.who.int/medicinedocs/en/d/Js4893e/9.html. Assessed on 24th May 2017.
Arora D. Pharmacovigilance an industry perspective. 1st ed. Sonepat: Pharmapublisher; 2012.
URL: http://www.cioms.ch. Assessed 31 Jan 2017.
URL: http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html. Assessed 31 Jan 2017.
URL: http://apps.who.int/medicinedocs/en/d/Jh2918e/32.html#Jh2918e.32.1. Assessed 22 Jan 2017.
URL: https://vigilyze.who-umc.org/#. Assessed 22 Jan 2017.
URL: https://www.who-umc.org/media/1417/umc_caveat_201605.pdf. Assessed 22 Jan 2017.
Acknowledgement
The authors express their gratitude to Ministry of Health and Family Welfare, Government of India and World Health Organization–Uppsala Monitoring Centre for providing technical support in the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kumar, R., Kalaiselvan, V., Singh, G.N. (2018). Topical Corticosteroids: The Pharmacovigilance Perspective. In: Lahiri, K. (eds) A Treatise on Topical Corticosteroids in Dermatology. Springer, Singapore. https://doi.org/10.1007/978-981-10-4609-4_32
Download citation
DOI: https://doi.org/10.1007/978-981-10-4609-4_32
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-4608-7
Online ISBN: 978-981-10-4609-4
eBook Packages: MedicineMedicine (R0)